Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Basile Edward M. Director active across 1 company, notably TransMedics Group, Inc.. In total, 12 filings have been logged. Breakdown: 0 buy · 5 sells. Total volume traded: €1.2m. History available since 27 February 2023. The latest transaction was disclosed on 20 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations12 total
2,922 shares0Common StockSEC:0001193125-26-236908:0
2,134 shares0Common StockSEC:0000950170-25-077227:0
6,000 shares@ US$0.700.2% of flowCommon StockSEC:0000950170-25-070568:0
6,750 shares@ US$28.1210.9% of flowCommon StockSEC:0000950170-24-123425:0
6,750 shares@ US$28.1210.9% of flowCommon StockSEC:0000950170-24-094079:0
1,193 shares@ US$138.089.5% of flowCommon StockSEC:0000950170-24-070709:0
732 shares0Common StockSEC:0000950170-24-065406:0
2,130 shares@ US$128.4316.0% of flowCommon StockSEC:0000950170-24-055798:0
5,773 shares@ US$86.2729.1% of flowCommon StockSEC:0000950170-24-012810:0
1,193 shares0Common StockSEC:0000950170-23-024878:0
3,500 shares@ US$80.1016.6% of flowCommon StockSEC:0000899243-23-006755:0
1,500 shares@ US$76.206.8% of flowCommon StockSEC:0000950170-23-005192:0